口服纳米配方通过淋巴运输改善胰腺小岛功能障碍,用于抗糖尿病治疗
Lin Hou1,2,3, Xueyuan Peng1,2, Ruiting Wang1,2
1School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Acta pharmaceutica Sinica. B
|July 31, 2023
概括
一种新的纳米颗粒配方可口服提供氧化,以准胰腺细胞,改善2型糖尿病治疗. 这种增强的输送系统恢复了岛屿细胞功能和葡萄糖平衡,每天给药.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 内分泌学 在内分泌学.
背景情况:
- 2型糖尿病 (T2DM) 治疗面临的挑战包括长期药物制和逐渐破坏胰腺β细胞.
- 有关口服配方的急需,这些配方可以增强患者的服药性,并保持β细胞功能.
研究的目的:
- 设计和评估一种纳米粒子系统,以提高口服吸收和针对性地向T2DM治疗的胰腺小岛输送.
- 恢复β细胞的生存和功能,从而改善系统性葡萄糖平衡.
主要方法:
- 开发一个纳米粒子系统 (PLGA-TCA/DLPC/HCQ),利用taurocholic acid (TCA) 通过胆酸载体介导吸收和淋巴运输向胰腺.
- 充满氧化 (HCQ) 的治疗效果,并将1,2-dilauroyl-sn-glycero-3-phosphocholine (DLPC) 作为稳定剂和协同剂.
- 在体外和体内评估纳米粒子在逆转胰腺小岛损伤和功能障碍方面的有效性.
主要成果:
- 该PLGA-TCA/DLPC/HCQ纳米颗粒显示,增强了口服吸收和在胰腺中的积累.
- 每天一次服用该配方可逆转胰腺小岛损伤和功能障碍,有效控制高血糖.
- 治疗改善了氧化应激,调节了胰腺炎症微环境,并激活了PI3K/AKT信号通路,没有显著的毒性.
结论:
- 开发的纳米粒子系统为T2DM治疗提供了一个有前途的口服输送平台,增强药物吸收和胰腺向性.
- 这一策略为全面的T2DM管理提供了一个新的治疗途径,通过恢复β细胞功能和改善血糖控制.
相关概念视频
Insulin: Biosynthesis, Chemistry, and Preparation
431
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
431
Oral Hypoglycemic Agents: Glinides
186
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
186
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.3K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.3K
Insulin Formulations: Types and Delivery
228
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
228
Oral Hypoglycemic Agents: Biguanides and Glitazones
234
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
234


